経カテーテル治療の世界市場

■ 英語タイトル:Transcatheter Treatment: Procedures and Heart Valve Market

調査会社BCC Research社が発行したリサーチレポート(データ管理コード:BCC21AP036)■ 発行会社/調査会社:BCC Research
■ 商品コード:BCC21AP036
■ 発行日:2021年2月
■ 調査対象地域:グローバル
■ 産業分野:医療
■ ページ数:144
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後2営業日)
■ 販売価格オプション(消費税別)
Single UserUSD5,500 ⇒換算¥814,000見積依頼/購入/質問フォーム
Multi UserUSD6,600 ⇒換算¥976,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
BCC Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[経カテーテル治療の世界市場]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

本調査レポートでは、経カテーテル治療の世界市場を調査・分析し、イントロダクション、サマリー・ハイライト、構造的心臓弁膜症、大動脈弁疾患、僧帽弁疾患、三尖弁膜症疾患、市場規模/成長分析、競争状況、企業市場戦略、医療機器価格/償還、経カテーテル治療装置の展望、企業情報などを掲載しています。
・イントロダクション
・サマリー・ハイライト
・構造的心臓弁膜症
・大動脈弁疾患
・僧帽弁疾患
・三尖弁膜症疾患
・市場規模/成長分析
・競争状況
・企業市場戦略
・医療機器価格/償還
・経カテーテル治療装置の展望
・企業情報

Transcatheter treatment includes procedure types such as TAVR, TAVI, TMVR and TMVI.Transcatheter procedure approaches include transfemoral, transapical and transaortic procedures.

This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for transcatheter treatment for heart valve diseases. The format of this study includes the following -
- Detailed description, including demographics and cost burden, of heart valve diseases (e.g., valvular stenosis and regurgitation) and transcatheter procedure approaches (e.g., transfemoral, transapical and transaortic).
- Detailed description and analysis of transcatheter treatments devices including TAVR, TAVI, TMVR and TMVI devices.
- Market characterization, unmet need, market size and segmentation (by region and treatment).
- Market drivers and restraints.
- Detailed market projections through 2025.
- Competition and market shares.
- Key marketed and pipeline (R&D) products along with information about their regulatory status.
- Strategic landscape.
- Regulatory structure.
- Pricing and reimbursement.
- Observations and conclusions on the future of transcatheter treatment.
- Profiles of market participants and associations.

Report Includes -

- 27 data tables and 26 additional tables
- Descriptive overview of the global market for key transcatheter treatment procedures, heart valve systems, and techniques used for the treatment of valvular diseases
- Analyses of the global market trends, with data from 2019-2020, and projections of five-year compound annual growth rates (CAGRs) through 2025
- Estimation of the actual market size and revenue forecast for transcatheter treatment procedures, and their corresponding market share analysis based on product type, treatment procedure and other key market segments, with major geographic regions and countries involved
- Identification of promising new transcatheter techniques and devices still in the development and testing stages, and the probability of their successful commercialization in the next five years
- Market forecast and market potential for transcatheter treatment procedures based on pipeline devices, on account of their estimated probability of commercial launch
- Assessment of the impact of demographic, economic, and other factors that will drive future demand for the transcatheter treatment devices and technologies market
- Profile description of the market leading corporations within the industry, including Abbott Laboratories, Boston Scientific Corp., Edwards Lifesciences Corp., Medtronic Inc., and St. Jude Medical Inc.

Summary:
In 2019, the U.S. accounted for REDACTED of the global transcatheter treatment market, a value of REDACTED. The U.S. market should approach nearly REDACTED in 2020 and reach REDACTED by 2025, increasing at a CAGR of REDACTED from 2020 to 2025. By region, the U.S. is expected to maintain dominance in the global transcatheter treatment market. This is due to the growing geriatric population, increasing prevalence of structural heart diseases, continuous technological advancements, increasing investment in R&D, incentives for new product development, increasing adoption of transcatheter techniques, positive reimbursement and other healthcare reforms.

In 2019, Europe, Asia-Pacific and ROW (Rest of the World) had shares of about REDACTED, REDACTED and REDACTED of the global market, or REDACTED, REDACTED and REDACTED, respectively. The Europe, Asia-Pacific and ROW markets should approach REDACTED, REDACTED and REDACTED in 2020 and reach REDACTED, REDACTED and REDACTED by 2025, increasing at CAGRs of REDACTED, REDACTED and REDACTED from 2020 through 2025, respectively.

Europe is the second-largest market after the U.S., and there are many established and early-stage companies that are working to enter the European TAVR market by developing improved transcatheter heart valve devices. Although a few products are already approved and available in the market, new features and more advanced technologies are expected to further expand the eligible patient population. Germany currently has the largest volume of TAVR procedures among Western European nations. With regard to the European transcatheter treatment device market, it is growing mainly due to improved healthcare infrastructure, increasing prevalence of heart disease, improving diagnosis rates, and a growing demand for minimally invasive and catheter-based treatment options.

The Asian market for transcatheter treatment devices is expected to experience the highest growth among all four regions during the next five years for various reasons: a growing aging (greater than 60 years) population, increasing availability and affordability of treatment, increasing acceptance of transcatheter procedures and advanced technology-enabled products and solutions.Additionally, the increased patient population and improving diagnosis rate are likely to increase the demand for TAVR/TAVI and TMVR procedures within the region.

Japan is an established market in Asia-Pacific, while China and India are emerging markets that are growing rapidly.

*** レポート目次(コンテンツ)***

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology and Information Sources
Geographic Breakdown
Analyst’s Credentials

Chapter 2 Summary and Highlights

Chapter 3 Structural Heart Valve Disease
Disease Overview
Spectrum of Structural Heart Disease
Valvular Heart Disease
Symptoms and Risk Factors of Structural Heart Disease
Causes of Structural Heart Disease
Rheumatic Fever
Mitral Valve Prolapse
Peripheral Artery Disease
Cardiovascular Disease
Aortic Aneurysm
Obesity
Diagnosis of Structural Heart Disease
Treatment of Structural Heart Disease
Management Through Medication
Surgical Intervention: Heart Valve Repair and Replacement
Tobacco Smoking and Heart Disease
Aging, Gender and Structural Heart Diseases
Global Demographics
U.S. Demographics
European Demographics
Japanese Demographics
Current Challenges and Future Directions

Chapter 4 Aortic Valve Disease
Disease Overview
Types of Aortic Stenosis
Acquired Aortic Stenosis
Congenital Aortic Stenosis
Mild and Moderate Aortic Stenosis
Severe Aortic Stenosis
Asymptomatic Aortic Stenosis
Symptomatic Aortic Stenosis
Causes, Risk Factors and Symptoms
Causes
Symptoms
Risk Factors
Epidemiology and Economic Burden
Diagnosis
Standard Doppler Echocardiography
Multimodality Imaging
Other Techniques
Treatment
Open Surgical Treatment (SAVR)
Transcatheter Treatment (TAVR/TAVI)
Aortic Valve Repair Versus Aortic Valve Replacement
Types of Transcatheter Approaches
Open Surgical Repair (SAVR) versus Transcatheter Treatment (TAVR/TAVI)
TAVR and TAVI Complications
Key Marketed and Pipeline Products
Key Marketed Products
Key Pipeline/R&D Products
Unmet Need
Current Challenges and Future Developments

Chapter 5 Mitral Valve Disease
Disease Overview
Types of Mitral Regurgitation
Disease Origin
Disease Stage
Disease Symptoms
Causes, Risk Factors and Symptoms
Causes
Symptoms
Risk Factors
Epidemiology and Economic Burden
Diagnosis
Standard Echocardiography
Multimodality Imaging
Other Techniques
Treatment
Open Surgical Treatment (SMVR)
Transcatheter Treatment (TMVR and TMVI)
Mitral Valve Repair Versus Mitral Valve Replacement
Types of Transcatheter Approaches
Open Surgery (SMVR) Versus Transcatheter Treatment (TMVR/TMVI)
TMVR Complications
Key Marketed and Pipeline Products
Key Marketed Products
Key Pipeline/R&D Products
Other Less-Invasive (MIS) Mitral Valve Technologies
Unmet Need
Current Challenges and Future Developments

Chapter 6 Tricuspid Valve Disease
Disease Overview
Types of Tricuspid Regurgitation
Primary Tricuspid Regurgitation
Secondary Mitral Regurgitation
Causes, Risk Factors and Symptoms
Causes
Symptoms
Epidemiology
Diagnosis
Echocardiography and Grading
Other Techniques
Treatment
Medical Treatment
Tricuspid Valve Surgery
Key Marketed and Pipeline Products
Key Marketed Products
Key Pipeline/R&D Products

Chapter 7 Market Size and Growth Analysis
Overview
Market Size and Growth Analysis by Region
Market Size and Growth Analysis by Segment
Market Size and Growth Analysis by Procedure Approach
Market Size and Growth Analysis by Procedure (TAVR/TAVI, TMVR and TTVR)
Heart Valve Market: Traditional versus Transcatheter Heart Valves
Market Growth Drivers and Restraints
Market Growth Drivers
Market Restraints

Chapter 8 Competitive Landscape
Overview

Chapter 9 Company Market Strategies
Market Consolidation in Cardiovascular Device Market
Mergers and Acquisitions in the Transcatheter Treatment Device Market
Key Observations Regarding Transcatheter Device Industry
Future Strategic Landscape

Chapter 10 Regulatory Structure: Medical Devices
Regulatory Background
Regulatory Systems for Medical Devices by Region
U.S.
European Union (EU)
Japan

Chapter 11 Pricing and Reimbursement: Medical Devices
Pricing and Reimbursement Background
Pricing and Reimbursement for Medical Devices by Region
United States
Europe
Japan

Chapter 12 Conclusions: Outlook for Transcatheter Treatment Devices
Major Developments Influencing the Market
Technological Developments
Demographic and Economic Trends
Changing Structure of the Healthcare Industry
Long-Term Outlook for Transcatheter Treatments

Chapter 13 Company Profiles
ABBOTT LABORATORIES
BIOTRONIK
BOSTON SCIENTIFIC CORP.
BRACCO SPA
BRAILE BIOMEDICA
CARDIAC DIMENSIONS INC.
COLIBRI HEART VALVE LLC
DIRECT FLOW MEDICAL INC.
EDWARDS LIFESCIENCES CORP.
GORMAN CARDIOVASCULAR RESEARCH GROUP
HANSEN MEDICAL INC. (SUBSIDIARY OF AURIS HEALTH INC.)
HIGHLIFE SAS
JENAVALVE TECHNOLOGY INC.
MEDTRONIC INC.
MICRO INTERVENTIONAL DEVICES INC.
MICROPORT SCIENTIFIC
MITRASSIST LTD.
MVRX INC.
NAVIGATE CARDIAC STRUCTURES INC.
NEOVASC INC.
ST. JUDE MEDICAL INC. (SUBSIDIARY OF ABBOTT LABORATORIES)
VENUS MEDTECH INC.

Chapter 14 Appendix A: List of Acronyms

Chapter 15 Appendix B: Professional Organizations
American Heart Association
Center for Drug Evaluation and Research (CDER)
Center for Devices and Radiological Health (CDRH)
Centers for Medicare & Medicaid Services (CMS)
European Databank for Medical Devices (EUDAMED)
Food and Drug Administration (FDA or USFDA)
Hormone Foundation
International Diabetes Federation (IDF)
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Network for Excellence in Health Innovation (NEHI)
National Center for Biotechnology Information (NCBI)
National Institute of Aging (NIA)
Pharmaceuticals and Medical Devices Agency (PMDA)
World Cancer Research Fund International
World Health Organization (WHO)



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(BCC21AP036 )"経カテーテル治療の世界市場" (英文:Transcatheter Treatment: Procedures and Heart Valve Market)はBCC Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。